Akari Therapeutics (AKTX) Cash & Equivalents Growth (3y) (2014 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -51.77% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 24.73% |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -28.55% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 13.33% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -16.07% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 21.66% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.88% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 36.53% |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -26.77% |
| Jun 30, 2025 | -30.72% |
| Mar 31, 2025 | -46.35% |
| Dec 31, 2024 | 553.35% |
| Sep 30, 2024 | -44.85% |
| Jun 30, 2024 | -33.27% |
| Mar 31, 2024 | -41.87% |
| Dec 31, 2023 | -91.24% |
| Jun 30, 2023 | 1.30% |
| Dec 31, 2022 | 32.35% |
| Jun 30, 2022 | 43.88% |
| Mar 31, 2022 | 40.98% |
| Dec 31, 2021 | -88.36% |
| Sep 30, 2021 | 9.95% |
| Jun 30, 2021 | -2.30% |
| Mar 31, 2021 | -34.55% |
| Dec 31, 2020 | 488.07% |
| Sep 30, 2020 | -16.26% |
| Jun 30, 2020 | -27.96% |
| Mar 31, 2020 | -38.78% |
| Dec 31, 2019 | -44.87% |
| Sep 30, 2019 | -55.76% |
| Jun 30, 2019 | -65.88% |
| Mar 31, 2019 | -54.03% |
| Dec 31, 2018 | -55.89% |
| Sep 30, 2018 | 44.66% |
| Jun 30, 2018 | 65.45% |
| Mar 31, 2018 | 161.58% |
| Dec 31, 2017 | 103.66% |
| Sep 30, 2017 | 635.97% |
| Jun 30, 2017 | 44.26% |
| Mar 31, 2017 | 35.10% |
| Dec 31, 2016 | 294.97% |
| Dec 31, 2015 | 296.70% |
| Dec 31, 2014 | 721.59% |